Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study

BACKGROUND: Despite aggressive treatment regimens comprising surgery and radiochemotherapy, glioblastoma (GBM) remains a cancer entity with very poor prognosis. The development of novel, combined modality approaches necessitates adequate preclinical model systems and therapy regimens that closely re...

Descripción completa

Detalles Bibliográficos
Autores principales: Stegen, Benjamin, Nieto, Alexander, Albrecht, Valerie, Maas, Jessica, Orth, Michael, Neumaier, Klement, Reinhardt, Sabine, Weick-Kleemann, Moritz, Goetz, Wilfried, Reinhart, Merle, Parodi, Katia, Belka, Claus, Niyazi, Maximilian, Lauber, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977274/
https://www.ncbi.nlm.nih.gov/pubmed/31969174
http://dx.doi.org/10.1186/s13014-020-1470-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977274/
https://www.ncbi.nlm.nih.gov/pubmed/31969174
http://dx.doi.org/10.1186/s13014-020-1470-2

Ejemplares similares